Ivoclar Vivadent has just announced the availability of Callisto® CPG, an exciting new entry in controlled price nobel alloys. With a controlled alloy price, laboratories can establish a fixed fee schedule for their PFM or press-to-metal restorations, without being affected by the current precious metal market. Following the same strategy as Callisto CP+, laboratories can continue to benefit from insurance reimbursement for noble alloys provided to patients.
Ivoclar Vivadent has just announced the availability of Callisto® CPG, an exciting new entry in controlled price nobel alloys. With a controlled alloy price, laboratories can establish a fixed fee schedule for their PFM or press-to-metal restorations, without being affected by the current precious metal market. Following the same strategy as Callisto CP+, laboratories can continue to benefit from insurance reimbursement for noble alloys provided to patients.
Callisto® CPG features a low density of 9.3, enabling laboratories to process more units at lower fabrication costs. Callisto® CPG is a cobalt-chrome-based ceramic alloy containing palladium and gold that demonstrates excellent physical properties. With high strength values, it is ideally suited for layering and press techniques.
Callisto® CPG can be used for onlays, crowns, 3/4 crowns, ceramic crowns, short- and long-span bridges, telescope and conus crowns, root canal posts, implant superstructures, partial dentures and model casting. Callisto® CPG is also compatible with the most popular veneering ceramics and is free of silver, copper, nickel and beryllium.
For more information, call 1-800-533-6825 in the U.S., 1-800-263-8182 in Canada.You can also visit www.ivoclarvivadent.com.